News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma
Collage photo of Mateo Mejia, Ruben Niesvizky and Mark Bustoros
Aug 12, 2024, 03:20

Using lymphocyte count to predict CAR-T cell therapy efficacy in relapsed multiple myeloma

WCM Myeloma Center posted on X:

“New research led by Drs. Mateo Mejia, Ruben Niesvizky and Mark Bustoros showed that a simple blood test may help predict whether patients with relapsed Multiple Myeloma will respond to chimeric antigen (CAR) T-cell therapy.”

Read Further.
Source: WCM Myeloma Center/X

cancer Mark Bustoros Mateo Mejia multiple myeloma OncoDaily Oncology Ruben Niesvizky WCM Myeloma Center
Special Coverage
Insight
Aug 14, 2025, 19:00
Why 87% of Digital Health Partnerships Fail - CancerX
Voices
Aug 14, 2025, 18:48
Tracey O'Brien: An Inspiring Start to the Inaugural NSW Cancer Summit 2025
Voices
Aug 14, 2025, 18:31
Jia (Jenny) Liu: Wonderful Talks by Ecaterina Dumbrava at MOGA25 on Drug Development
Voices
Aug 14, 2025, 18:18
Michael Jefford: Great to Present ePROs Work from Julia Lai-Kwon’s PhD at MOGA25 ASM
Voices
Aug 14, 2025, 17:56
Leading with Humanity: The Humanitarian PACT - The Max Foundation
Voices
Aug 14, 2025, 17:38
Shane Jacobson Leads the American Cancer Society into a New Era of Cancer Advocacy and Care
Voices
Aug 14, 2025, 17:30
Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding
Career Updates
Aug 14, 2025, 17:20
Namrata Singh Has Been Promoted to Technical Director of the Core Pathology Lab at Dana-Farber
Career Updates
Aug 14, 2025, 17:07
Loredana Vecchionen Begins Role as Hematologist, Oncologist, and Clinician Scientist at Charité
Voices
Aug 14, 2025, 16:54
Nicholas DeVito: Looking For a Crash Course in Tumor Immunology and Immunotherapy?
Science
Aug 14, 2025, 16:44
Drew Moghanaki: The Results from the Phase 3 HARMONi Trial Will be Presented at WCLC25
Science
Aug 14, 2025, 16:27
Study Lead by Jordan Gauthier Finds How ICIs Affect CAR T-Cell Function and the TME in PMBCL